OPTION TO LICENSE AGREEMENTOption to License Agreement • May 31st, 2011 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations
This Option to License Agreement (the “Agreement”) is entered into as of this day of September, 2010 (the “Effective Date”), by and among Yeda Research and Development Company Limited, a company formed and existing under the laws of the State of Israel, having a place of business at the Weizmann Institute of Science, POB 95, Rehovot, 76100, Israel (“Yeda”), and XTL Biopharmaceuticals, Ltd or any of its affiliates, a company formed under and existing the laws of the State of Israel, having a place of business at Kiryat Weizmann Science Park, Bldg. 3, POB 370, Rehovot, 76100, Israel (the “Company”).
OPTION TO LICENSE AGREEMENT FOROption to License Agreement • October 31st, 2022 • Connecticut
This Option to License Agreement For Fuel Cell Energy Facility Power Purchase and License Agreement (the “Option Agreement”) is made this day of , 20 (the “Effective Date”) by and between the Town of Stratford, Connecticut, a municipal corporation existing under and by virtue of the laws of the State of Connecticut with an address of 2725 Main St, Stratford, CT 06615 (the “Town” or “Owner”), and [Fuel Cell Developer], a [STATE] limited liability company whose principal place of business is located at [ADDRESS] (the “Grantee”). Each of Owner and Grantee is sometimes referred to as a “Party” and collectively as the “Parties.”
Subject to Contract / Contract DeniedOption to License Agreement • March 27th, 2019
[●] (the “RPO”), [an academic institution incorporated or established under [statute or charter in Ireland],] whose [principal address or registered office] is at [●]; and
